De Novo Advancements in Pharmaceutical Sciences

MAY 4-8, 2018 Melbourne, Australia: Conference Series, host of 15th Asia-Pacific Pharma Congress on Pharmaceutical Sciences, a unique Pharma Conference that discusses the latest advancements emerging in the field of pharmaceutical sciences. Asia Pharma 2018 will provide interactive sessions regarding the latest advancements emerging in the field along with recent advances. It also provides an opportunity to showcase your innovation in front of the world for the global recognition. Asia Pharma 2018 is the 15th Asia Pharma Congress, show in Australia. The event is held at Mercure Melbourne Albert Park, Melbourne, Australia, from 18-20 July 2018.
The conference will feature keynote presentations by top professionals as well as renowned experts in the field from all around the globe. Osama Ibrahim, Principal Research Scientist & Biotechnology Consultant, Bio Innovation, USA; Dilip Ghosh, Principal Consultant, Soho Flordis International, Australia; Mohamed E E Shams, Professor, University of Mansoura Egypt; Md. Faiyazuddin, Eduardo Principal Bihar College of Pharmacy, will present their lectures during the conference. These are all among other exciting and high-profile individuals who have shared knowledge of their experience in the field of Pharmaceutical Sciences. In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for pharmacy educators, practitioners and researchers to exchange & share their experiences, research findings about all aspects of Pharmacy and Pharmaceutical Sciences.
Asia Pharma 2018 brought together the International blend of people from pharmaceutical, biotech & medical devices companies, business entrepreneurs, pharmaceutical consultants, R&D heads and decision makers from pharmaceuticals, contract research, clinical trials, leading universities and research institutions making it the largest endeavor from Conference Series. All the papers presented at this conference were published in special issue of Journal of Hospital and Clinical Pharmacy.
Conference Highlights:
• 200+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 30+ Plenary Speakers
• 5+ Exhibitors
• 18+ Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings
Australian Pharmaceutical Industry is one of the largest and most advanced among the developing countries. It is set to ascend from simply over $22.85 billion in 2016 to $25.2 billion by 2020, as indicated by research and counseling firm Global Data. The reports highlight various open doors open to organizations planning to put resources into the Australian pharmaceutical industry, including expanding outside direct venture (FDI), the developing nonexclusive medications advertise, and a good duty condition. Other central point driving development in Australia's pharmaceuticals advertise incorporate the expanding elderly populace and its related malady trouble, alongside all around characterized administrative rules and the rising commonness of non-transmittable ailments because of an inexorably inactive lifestyle. Australia's human services market is set to develop to an amazing $42.5 billion by 2020, driven by all-inclusive social insurance scope given by Medicare and great access to offices, for example, government-sponsored drugs, as indicated by research and counseling firm Global Data.
If you would like to know more information about this conference, Contact: Robert Brown
Tel.: +1-6508894686
Email: [email protected]
Website: https://asiapacific.pharmaceuticalconferences.com/